Thrombotic manifestations of antiphospholipid syndrome are often a therapeutic dilemma
and challenge. Despite our increasing knowledge of this relatively new disease, many …

Persistent serum positivity for antiphospholipid antibodies (aPL) is required to diagnose
antiphospholipid syndrome (APS), an autoimmune disease characterized by recurrent …

Thrombotic antiphospholipid syndrome (APS) is characterised by venous, arterial and/or
small vessel thrombosis in the context of persistently positive antiphospholipid antibodies …

Indefinite anticoagulation remains the mainstay of treatment for thrombotic APS. Despite
advances in diagnostic techniques, it remains difficult to predict thrombotic risk in …

Antiphospholipid syndrome (APS) is characterized by thrombosis (which may be venous,
arterial, or microvascular) and/or pregnancy morbidity in association with persistently …

Background Antiphospholipid syndrome (APS) or 'Hughes syndrome'is a prothrombotic
disease characterized by thrombosis and pregnancy morbidity in the presence of …

Vascular thrombosis and pregnancy morbidity represent the clinical manifestations of
antiphospholipid syndrome (APS), which is serologically characterized by the persistent …

Background Antiphospholipid syndrome (APS) is an acquired hypercoagulable condition
associated with antiphospholipid antibody (aPL) presence. Data on re-thrombosis following …

Antiphospholipid Syndrome (APS) is a condition characterized by the occurrence of
thromboembolic events and/or pregnancy loss combined with one laboratory criterion …

The antiphospholipid syndrome (APS) is defined by venous or arterial thrombosis and/or
pregnancy morbidity in patients with persistent presence of antiphospholipid antibodies …